An alternative to warfarin for patients with PE

dc.contributor.author	Morris, Laura	eng
dc.contributor.author	Stevermer, James J.	eng
dc.contributor.other	Family Physicians Inquiries Network	eng
dc.date.issued	2012	eng
dc.description.abstract	Consider treating patients with acute pulmonary embolism (PE) with rivaroxaban, a factor Xa inhibitor; it works as well as low-molecular-weight heparin (LMWH) followed by warfarin, but may cause fewer major bleeds. Stength of recommendation: B: Based on a single, nonblinded randomized controlled trial.	eng
dc.identifier.uri	http://hdl.handle.net/10355/16182
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Priority Updates to Research Literature (PURLs) (2012)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 61, no. 12 (December 2012): 751-752.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject.lcsh	Pulmonary embolism -- Alternative treatment	eng
dc.subject.lcsh	Wayfarin -- Side effects	eng
dc.subject.lcsh	Anticoagulants (Medicine) -- Effectiveness	eng
dc.subject.other	Pulmonary embolism	eng
dc.subject.other	Rivaroxaban	eng
dc.title	An alternative to warfarin for patients with PE	eng
dc.type	Article	eng

Priority Updates to Research Literature (PURLs)
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.